249 related articles for article (PubMed ID: 9483162)
1. When and how to assess fast-changing technologies: a comparative study of medical applications of four generic technologies.
Mowatt G; Bower DJ; Brebner JA; Cairns JA; Grant AM; McKee L
Health Technol Assess; 1997; 1(14):i-vi, 1-149. PubMed ID: 9483162
[TBL] [Abstract][Full Text] [Related]
2. Telemedicine for the Medicare population: pediatric, obstetric, and clinician-indirect home interventions.
Hersh WR; Wallace JA; Patterson PK; Shapiro SE; Kraemer DF; Eilers GM; Chan BK; Greenlick MR; Helfand M
Evid Rep Technol Assess (Summ); 2001 Aug; (24 Suppl):1-32. PubMed ID: 11569328
[TBL] [Abstract][Full Text] [Related]
3. Procedures and methods of benefit assessments for medicines in Germany.
Bekkering GE; Kleijnen J
Eur J Health Econ; 2008 Nov; 9 Suppl 1():5-29. PubMed ID: 18987905
[TBL] [Abstract][Full Text] [Related]
4. [Procedures and methods of benefit assessments for medicines in Germany].
Bekkering GE; Kleijnen J
Dtsch Med Wochenschr; 2008 Dec; 133 Suppl 7():S225-46. PubMed ID: 19034813
[TBL] [Abstract][Full Text] [Related]
5. Health-related quality of life in early breast cancer.
Groenvold M
Dan Med Bull; 2010 Sep; 57(9):B4184. PubMed ID: 20816024
[TBL] [Abstract][Full Text] [Related]
6. Statistical assessment of the learning curves of health technologies.
Ramsay CR; Grant AM; Wallace SA; Garthwaite PH; Monk AF; Russell IT
Health Technol Assess; 2001; 5(12):1-79. PubMed ID: 11319991
[TBL] [Abstract][Full Text] [Related]
7. How has the impact of 'care pathway technologies' on service integration in stroke care been measured and what is the strength of the evidence to support their effectiveness in this respect?
Allen D; Rixson L
Int J Evid Based Healthc; 2008 Mar; 6(1):78-110. PubMed ID: 21631815
[TBL] [Abstract][Full Text] [Related]
8. When is the 'right' time to initiate an assessment of a health technology?
Mowatt G; Bower DJ; Brebner JA; Cairns JA; Grant AM; McKee L
Int J Technol Assess Health Care; 1998; 14(2):372-86. PubMed ID: 9611910
[TBL] [Abstract][Full Text] [Related]
9. Using routine data to complement and enhance the results of randomised controlled trials.
Lewsey JD; Leyland AH; Murray GD; Boddy FA
Health Technol Assess; 2000; 4(22):1-55. PubMed ID: 11074392
[TBL] [Abstract][Full Text] [Related]
10. Trial design and reporting standards for intra-arterial cerebral thrombolysis for acute ischemic stroke.
Higashida RT; Furlan AJ; Roberts H; Tomsick T; Connors B; Barr J; Dillon W; Warach S; Broderick J; Tilley B; Sacks D; ;
Stroke; 2003 Aug; 34(8):e109-37. PubMed ID: 12869717
[TBL] [Abstract][Full Text] [Related]
11. 'Early warning systems' for identifying new healthcare technologies.
Robert G; Stevens A; Gabbay J
Health Technol Assess; 1999; 3(13):1-108. PubMed ID: 10632623
[No Abstract] [Full Text] [Related]
12. Time-trends in health technology assessments: an analysis of developments in composition of international health technology assessments from 1989 to 2002.
Draborg E; Gyrd-Hansen D
Int J Technol Assess Health Care; 2005; 21(4):492-8. PubMed ID: 16262973
[TBL] [Abstract][Full Text] [Related]
13. Regarding: Rosenthal DI, Glatstein E. "We've Got a Treatment, but What's the Disease?" The Oncologist 1996;1.
Lunsford LD; Flickinger JC; Larson D
Oncologist; 1997; 2(1):59-61. PubMed ID: 10388030
[TBL] [Abstract][Full Text] [Related]
14. [Telemedicine and medical technology assessment].
Myhre KI
Tidsskr Nor Laegeforen; 2000 Aug; 120(19):2312-4. PubMed ID: 10997095
[TBL] [Abstract][Full Text] [Related]
15. [The Danish Health Technology Assessment model. A systematic review of Danish HTAs published by CEMTV from 1998 to 2004].
Draborg EU
Ugeskr Laeger; 2006 May; 168(21):2074-8. PubMed ID: 16768927
[TBL] [Abstract][Full Text] [Related]
16. Strategies for successful evaluation and policy-making toward health care technology on the move: the case of medical lasers.
Banta HD; Vondeling H
Soc Sci Med; 1994 Jun; 38(12):1663-74. PubMed ID: 8047925
[TBL] [Abstract][Full Text] [Related]
17. The changing environment for technological innovation in health care.
Goodman CS; Gelijns AC
Baxter Health Policy Rev; 1996; 2():267-315. PubMed ID: 11066263
[TBL] [Abstract][Full Text] [Related]
18. Factors influencing health insurers' decisions to cover new genetic technologies.
Schoonmaker MM; Bernhardt BA; Holtzman NA
Int J Technol Assess Health Care; 2000; 16(1):178-89. PubMed ID: 10815363
[TBL] [Abstract][Full Text] [Related]
19. Introduction and uptake of new medical technologies in the Australian health care system: a qualitative study.
Gallego G; Casey R; Norman R; Goodall S
Health Policy; 2011 Oct; 102(2-3):152-8. PubMed ID: 21601934
[TBL] [Abstract][Full Text] [Related]
20. The new NICE Evaluation Pathway for medical technologies.
Campbell B
Ann R Coll Surg Engl; 2010 Jul; 92(5):435-6. PubMed ID: 20653073
[No Abstract] [Full Text] [Related]
[Next] [New Search]
